PR Newswire
KELOWNA, BC
,
Jan. 11, 2021
/PRNewswire/ –
The Valens Company Inc.
(TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce that
Tyler Robson
, CEO of The Valens Company, will participate in the ATB Capital Markets 9th Annual Institutional Investor Conference being held on
January 12-14, 2021
.
Mr. Robson is scheduled to join
David Kideckel
, ATB Managing Director and Senior Research Analyst, for a fireside chat titled
“Cannabis 2.0… 3.0… and Beyond”
on
Thursday, January 14, 2021
at
9:00 am ET
. Management will also host one-on-one investor meetings throughout the duration of the conference.
About The Valens Company
The Valens Company is a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products. The Valens Company is focused on being the partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation and product development and custom manufacturing. Valens is the largest third-party extraction company in
Canada
with an annual capacity of 425,000 kg of dried cannabis and hemp biomass at our purpose-built facility in
Kelowna, British Columbia
which is in the process of becoming European Union (EU) Good Manufacturing Practices (GMP) compliant. The Valens Company currently offers a wide range of product formats, including tinctures, two-piece caps, soft gels, oral sprays and vape pens as well as beverages, concentrates, topicals, edibles, injectables, natural health products and has a strong pipeline of next-generation products in development for future release. Finally, The Valens Company’s wholly-owned subsidiary
Valens Labs
is a Health Canada licensed ISO 17025 accredited cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant-Based Science. For more information, please visit
. The Valens Company’s investor deck can be found specifically at
.
View original content to download multimedia:
http://www.prnewswire.com/news-releases/the-valens-company-ceo-to-participate-in-atb-capital-markets-9th-annual-institutional-investor-conference-301204796.html
SOURCE The Valens Company
